These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8742561)

  • 1. Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial.
    Diabetes Care; 1996 Mar; 19(3):195-203. PubMed ID: 8742561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events and their association with treatment regimens in the diabetes control and complications trial.
    Diabetes Care; 1995 Nov; 18(11):1415-27. PubMed ID: 8722064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of treatment protocols in the Diabetes Control and Complications Trial.
    Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications/Epidemiology of Diabetes Interventions and Complications cohort.
    Jacobson AM; Braffett BH; Cleary PA; Gubitosi-Klug RA; Larkin ME;
    Diabetes Care; 2013 Oct; 36(10):3131-8. PubMed ID: 23835693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.
    Am J Med; 1991 Apr; 90(4):450-9. PubMed ID: 2012085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
    ; Orchard TJ; Nathan DM; Zinman B; Cleary P; Brillon D; Backlund JY; Lachin JM
    JAMA; 2015 Jan; 313(1):45-53. PubMed ID: 25562265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial.
    Ann Intern Med; 1996 Feb; 124(4):379-88. PubMed ID: 8554246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group.
    Diabetes Care; 1988 Oct; 11(9):725-32. PubMed ID: 3066604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of urologic complications with health-related quality of life and perceived value of health in men and women with type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Interventions and Complications (DCCT/EDIC) cohort.
    Jacobson AM; Braffett BH; Cleary PA; Dunn RL; Larkin ME; Wessells H; Sarma AV;
    Diabetes Care; 2015 Oct; 38(10):1904-12. PubMed ID: 26203062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial.
    Am J Cardiol; 1995 May; 75(14):894-903. PubMed ID: 7732997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
    JAMA; 1996 Nov; 276(17):1409-15. PubMed ID: 8892716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group.
    Diabetes Care; 1988; 11(7):567-73. PubMed ID: 2904881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of a model to estimate the impact of type 1 diabetes on health-related quality of life.
    Wu SY; Sainfort F; Tomar RH; Tollios JL; Fryback DG; Klein R; Klein BE
    Diabetes Care; 1998 May; 21(5):725-31. PubMed ID: 9589231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diabetes Control and Complications Trial (DCCT).
    Keen H
    Health Trends; 1994; 26(2):41-3. PubMed ID: 10137725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes control and complications.
    Crofford OB
    Annu Rev Med; 1995; 46():267-79. PubMed ID: 7598463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A better future for children with type 1 diabetes: Review of the conclusions from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.
    Morales A
    J Ark Med Soc; 2009 Oct; 106(4):90-3. PubMed ID: 19813399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resource utilization and costs of care in the diabetes control and complications trial.
    Diabetes Care; 1995 Nov; 18(11):1468-78. PubMed ID: 8722072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomized controlled trial.
    O'Brien CL; Ski CF; Thompson DR; Moore G; Mancuso S; Jenkins A; Ward G; MacIsaac RJ; Loh M; Knowles SR; Rossell SL; Castle DJ
    Trials; 2016 Sep; 17(1):444. PubMed ID: 27612943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transition to young adulthood in youth with type 1 diabetes on intensive treatment.
    Insabella G; Grey M; Knafl G; Tamborlane W
    Pediatr Diabetes; 2007 Aug; 8(4):228-34. PubMed ID: 17659065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.